ipamorelin human clinical trial trials growth hormone secretion safety Figure 3 from Ipamorelin, the first selective secretagogue Ipamorelin 5mg – NewBioRx – ipamorelin clinical trial study – ipamorelin clinical trial lean body

One fuels cells

Research13 min read GLP-1 Agonists & Addiction: Emerging Research People taking [semaglutide](/peptides/semaglutide-complete-pharmacology-guide/) for weight loss or diabetes have been saying something unexpected for years now: they don't just want less food they want less alcohol, fewer cigarettes, and in some cases, less of whatever substance they'd been Research17 min read GLP-1 Agonists & Neurodegeneration Research Few topics in neuroscience have generated as much excitement -- and as much confusion -- as the idea that diabetes drugs might protect the brain from degenerative diseases

A Potential Reduction of Type 2 Diabetes With lower levels of glutathione and potential issues with glucose metabolism, diabetes type 2 causes extreme oxidative stress and damage

The underlying mechanisms are multifactorial and not fully understood, but increasing evidence highlights the gutbrain axis and the intestinal microbiome as critical contributors to disease onset and progression (He et al., 2023